621.83

2.43% 14.75

After Hours: 621.83

Thermo Fisher Scientific Inc (TMO)

Overview News Price History Option Chain Financials Why TMO Down? Discussions Forecast Stock Split Dividend History

Thermo Fisher Scientific Inc stock is traded at $621.83, with a volume of 2.46M. It is up +2.43% in the last 24 hours and up +8.66% over the past month. Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

Previous Close:

$607.08

Open:

$608.63

24h Volume:

2.46M

Relative Volume:

1.38

Market Cap:

$233.63B

Revenue:

$43.74B

Net Income/Loss:

$6.58B

P/E Ratio:

35.93

EPS:

17.3072

Net Cash Flow:

$6.11B

1W Performance:

+0.76%

1M Performance:

+8.66%

6M Performance:

+46.20%

1Y Performance:

+11.64%

1-Day Range:

$607.10

$622.72

1-Week Range:

$594.30

$624.79

52-Week Range:

$385.46

$628.08

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Name

Thermo Fisher Scientific Inc

Sector

Healthcare (1119)

Industry

Diagnostics & Research (52)

Phone

(781) 622-1000

Address

168 THIRD AVENUE, WALTHAM, MA

Employee

125,000

Twitter

@thermofisher

Next Earnings Date

2025-10-22

Latest SEC Filings

TMO's Discussions on Twitter

Compare TMO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMO Thermo Fisher Scientific Inc	621.83	228.08B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	237.95	166.39B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	710.48	57.02B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	145.92	41.48B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	241.35	41.14B	15.90B	1.28B	2.21B	7.2842

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-11-25	Upgrade	Citigroup	Neutral → Buy
Dec-09-25	Initiated	Goldman	Buy
Dec-08-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Dec-02-25	Resumed	Morgan Stanley	Overweight
Dec-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-11-25	Upgrade	Barclays	Equal Weight → Overweight
Aug-19-25	Initiated	William Blair	Outperform
Jul-24-25	Downgrade	HSBC Securities	Buy → Hold
Jul-11-25	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Jul-09-25	Downgrade	UBS	Buy → Neutral
Jan-10-25	Upgrade	Bernstein	Mkt Perform → Outperform
Dec-23-24	Initiated	Scotiabank	Sector Perform
Oct-14-24	Initiated	Redburn Atlantic	Buy
Oct-01-24	Initiated	Stephens	Overweight
Aug-28-24	Initiated	Wells Fargo	Overweight
Jun-03-24	Resumed	Jefferies	Buy
Mar-18-24	Resumed	Citigroup	Neutral
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight
Jan-08-24	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-18-23	Initiated	HSBC Securities	Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Oct-26-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-25-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Sep-28-23	Initiated	Bernstein	Outperform
Sep-06-23	Resumed	Citigroup	Buy
Jul-19-23	Initiated	Raymond James	Outperform
Jul-19-23	Reiterated	Robert W. Baird	Outperform
Jul-13-23	Upgrade	Credit Suisse	Neutral → Outperform
Apr-04-23	Reiterated	Barclays	Overweight
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Oct-27-22	Downgrade	The Benchmark Company	Buy → Hold
Aug-25-22	Initiated	Credit Suisse	Neutral
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Jan-26-22	Resumed	Barclays	Overweight
Oct-20-21	Upgrade	Citigroup	Neutral → Buy
Oct-15-21	Resumed	Cowen	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Jul-16-21	Initiated	The Benchmark Company	Buy
Mar-18-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jan-08-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-16-20	Downgrade	Citigroup	Buy → Neutral
Dec-02-20	Initiated	Goldman	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-30-20	Initiated	Atlantic Equities	Overweight
Sep-14-20	Initiated	Morgan Stanley	Overweight
Aug-20-20	Resumed	JP Morgan	Overweight
Jul-15-20	Upgrade	Cleveland Research	Neutral → Buy
Jul-07-20	Reiterated	Needham	Buy
Apr-23-20	Reiterated	Needham	Buy
Jan-31-20	Reiterated	Needham	Buy
Jan-22-20	Initiated	Credit Suisse	Neutral
Jan-08-20	Initiated	Wells Fargo	Equal Weight
Jan-07-20	Initiated	Citigroup	Buy
Nov-15-19	Initiated	Stifel	Buy
Jul-25-19	Reiterated	Needham	Buy
Jul-16-19	Downgrade	Needham	Strong Buy → Buy
May-30-19	Initiated	Wolfe Research	Outperform
May-23-19	Reiterated	Needham	Strong Buy
Apr-22-19	Reiterated	Needham	Strong Buy
Apr-16-19	Reiterated	BofA/Merrill	Buy

View All

Thermo Fisher Scientific Inc Stock (TMO) Latest News

Jan 14, 2026

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom - TechStock²

Jan 14, 2026

Thermo Fisher closes manufacturing site, lays off hundreds - The Business Journals

Jan 14, 2026

Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle - TechStock²

Jan 14, 2026

Thermo Fisher Scientific launches new Niton XL5e Analyzer - International Mining

Jan 14, 2026

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? - TradingView — Track All Markets

Jan 14, 2026

Company Profile – Thermo Fisher Scientific - pharmaphorum

Jan 14, 2026

Thermo Fisher Sci.: The Quiet Giant Wall Street Loves (But TikTok Still Sleeps On) - AD HOC NEWS

Jan 14, 2026

Will Thermo Fisher’s AI Push and Leadership Shuffle Redefine TMO’s Innovation and Execution Narrative? - simplywall.st

Jan 14, 2026

Jan 13, 2026

Niton adds to handheld analyzer line - Construction & Demolition Recycling

Jan 13, 2026

Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus - TechStock²

Jan 13, 2026

Thermo Fisher Scientific Projects Revenue Growth of Over 7 Percent by 2028 Driven by Strategic M&A Efforts - geneonline.com

Jan 13, 2026

Platinum-Based Catalysts Market Outlook to 2029 & 2034: Revenues to Reach $4.98 Billion by 2029In - PharmiWeb.com

Jan 13, 2026

Viega North America hires Thermo Fisher Scientific VP as COO - BizWest

Jan 13, 2026

Thermo Fisher wins contracts as pharma shifts production to US, CEO says - Reuters

Jan 13, 2026

JPM26: ThermoFisher ‘very positive’ on strategic M&A as deals expand capabilities - Yahoo Finance

Jan 13, 2026

Thermo Fisher Sci.: How a Quiet Giant Is Building the Operating System of Modern Science - AD HOC NEWS

Jan 13, 2026

Thermo Fisher stock slides as Nvidia AI lab deal meets COO exit and March reshuffle - TechStock²

Jan 13, 2026

Thermo Fisher Scientific and NVIDIA collaborating to scale AI-based laboratory automation - chemengonline.com

Jan 13, 2026

JPM: Nvidia Launches AI Collaborations with Eli Lilly, Thermo Fisher - Genetic Engineering and Biotechnology News

Jan 13, 2026

Thermo Fisher Scientific Launches New SmartRaman+ Spectrometer - Contract Pharma

Jan 13, 2026

Thermo Fisher Expands Handheld XRF Line with New High-End Analyzer for Field Use - Spectroscopy Online

Jan 13, 2026

TetraScience Announces Collaboration with Thermo Fisher Scientific to Accelerate Scientific Data and AI Enablement Across the Laboratory | Corporate - EQS News

Jan 13, 2026

Thermo Fisher partners with NVIDIA on AI-driven lab automation - Engineering.com

Jan 13, 2026

Thermo Fisher Scientific And NVIDIA Partner To Advance AI-Powered Laboratory Automation - Nasdaq

Jan 13, 2026

Jan 12, 2026

Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance - 01net

Jan 12, 2026

Lobbying Update: $30,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative

Jan 12, 2026

Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up - TechStock²

Jan 12, 2026

Thermo Fisher (TMO) Partners with Nvidia to Enhance AI in Labs - GuruFocus

Jan 12, 2026

Thermo Fisher partners with NVIDIA to develop AI-powered lab solutions - Investing.com

Jan 12, 2026

Thermo Fisher partners with NVIDIA to develop AI-powered lab solutions By Investing.com - Investing.com South Africa

Jan 12, 2026

Thermo Fisher, Nvidia announce strategic collaboration - TipRanks

Jan 12, 2026

Thermo Fisher Scientific Announces Strategic Collaboration with NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance - marketscreener.com

Jan 12, 2026

Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects - Fierce Biotech

Jan 12, 2026

TetraScience Collaborates with Thermo Fisher to Advance Scientific AI Across Biopharma R&D - HPCwire

Jan 12, 2026

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk - TechStock²

Jan 12, 2026

Thermo Fisher Scientific WARN Act Investigation - Strauss Borrelli PLLC

Jan 12, 2026

Thermo Fisher Scientific Inc. Promotes Marc N. Casper as Chief Executive Officer, Effective March 1, 2026 - marketscreener.com

Jan 12, 2026

Nvidia Deepens Push Into Drug Discovery Via New Partnerships with Lilly, Thermo Fisher & More - MedCity News

Jan 12, 2026

Nvidia expands health platform as Eli Lilly and Thermo Fisher sign new AI partnerships | 2026-01-12 | Investing News - Stockhouse

Jan 12, 2026

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery - NVIDIA Newsroom

Jan 12, 2026

TetraScience Announces Collaboration with Thermo Fisher Scientific Inc. to Accelerate Scientific Data and AI Enablement Across the Laboratory - marketscreener.com

Jan 12, 2026

Sumitomo Mitsui Trust Group Inc. Buys 5,892 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Jan 12, 2026

Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery - GlobeNewswire Inc.

Jan 12, 2026